Homes247.in is India's First End-to-End Real Estate Service

Homes247.in is a giant in the Indian market. Helping consumers through the entire home buying lifecycle has placed it at the top. It’s the first end-to-end real estate platform in the country. 

As the world continues to battle the pandemic, services that can be completed online, from the safety of one’s home, is paramount. Homes247 has introduced its online homebuying features titled ‘Book a Home from Home’ in-line with this shift in consumer behavior. 

With Book a Home from Home, users can complete the entire process of house hunting with minimal human interaction. 

Book a Home from Home includes 3D virtual tours, as well as negotiations and bookings through its platform. 

Homes247 is a proptech company. It has deep experience in the utilization of technology to make the house buying process faster, more convenient, and more efficient. This has helped the company skyrocket to the top of the market with an impressive amount of support under its belt. 

Priyatham Kumar, the Founder and CEO of Homes247, said:

“We are one of the very few full-stack portals that offer services from search to settle. Other players lack the flexibility that we possess and are often burdened with limitations. Ours is also a zero-service-cost model. And, in the future, we also plan to inculcate data analytics as well as full-scale domestic services models.”

The company focuses very much on the needs of the consumer.  The pandemic is keeping consumers home and social distancing. Homes247’s fully end-to-end service allows for those trying to stay safe to continue looking for a home without risking their health. 

Millennial and Gen Z consumers have shown the startup that convenience and a frictionless experience are important to the average 20-something. Homes247 has also taken this into account when developing its fully end-to-end service. The service aligns with not only the safety procedures of the pandemic but with the needs of the younger generation, keeping this service relevant long after a COVID cure is developed.